The patient experience of CHAPLE disease: results from interviews conducted as part of a clinical trial for an ultra-rare condition is a research paper published in Orphanet Journal of Rare Diseases (2025). On theSindex it has a DataRank of 0.179. It has been cited 2 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0.0139
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
Regeneron Pharmaceuticals
Grant: Not applicable
FWCI
0.73
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of The patient experience of CHAPLE disease: results from interviews conducted as part of a clinical trial for an ultra-rare condition
Additional file 1 of The patient experience of CHAPLE disease: results from interviews conducted as part of a clinical trial for an ultra-rare condition